Mercado de Produtos de Traqueostomia Ásia-Pacífico – Tendências da Indústria e Previsão para 2030

Análise e dimensão do mercado de produtos de traqueostomia Ásia-Pacífico

Prevê-se que os casos de cancro do pulmão aumentem a nível mundial devido ao aumento de fumadores dependentes do tabaco. O cancro do pulmão é a forma de cancro mais frequente que resulta em mortes na Índia, de acordo com o Conselho Indiano de Investigação Médica ou ICMR. Acredita-se que esta doença tenha contribuído para 180 mil mortes em 2021. O cancro do pulmão é o segundo tipo de cancro mais comum nos homens e o terceiro tipo de cancro mais comum nas mulheres no Brasil, segundo dados do Instituto Nacional do Cancro do Brasil. O cancro do pulmão contribuiu para quase 34.000 mortes neste país em 2018. Prevê-se que um aumento dos casos de cancro do pulmão apoie a expansão do mercado durante o período de previsão.

A Data Bridge Market Research analisa que o mercado de produtos de traqueostomia, que é de 5.5051,54 mil dólares em 2022, deverá atingir os 93.883,90 mil dólares até 2030, com um CAGR de 6,9% durante o período de previsão de 2023 a 2030. Além dos insights sobre cenários de mercado como o valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research também incluem análises especializadas aprofundadas, epidemiologia de pacientes, análise de pipeline, análise de preços e enquadramento regulamentar.

Âmbito e segmentação do mercado de produtos de traqueostomia Ásia-Pacífico  

Definição de mercado

Uma traqueostomia é um conduto criado cirurgicamente que se estende pela parte anterior do pescoço e pela traqueia. O doente pode respirar através de um tubo inserido no orifício. Ao fazê-lo, evita-se o nariz, a boca e a garganta, o ar pode entrar no pulmão e as secreções pulmonares podem ser expelidas. Em circunstâncias graves, a traqueostomia é permanente. No entanto, se já não for necessário, o orifício será tapado. Este procedimento pode resultar em diversas consequências, incluindo hemorragias, danos vocais permanentes e infeções, entre outras. Os doentes com cancro no pescoço, lesões no pescoço, doenças pulmonares crónicas, suporte ventilatório a longo prazo e paralisia das cordas vocais, entre outras condições, são tratados com traqueostomias.

Dinâmica do mercado de produtos de traqueostomia Ásia-Pacífico

Motoristas

• Aumento de doenças respiratórias

The rise in respiratory illnesses such asthma, exercise-induced bronchospasm, emphysema, allergic rhinitis, primary dysmenorrhea, pneumonia and lung cancer is the main driver driving the market's expansion. For instance, the COPD prevalence was higher in smokers compared to non-smokers and the majority of the national data revealed that COPD was diagnosed in about 6.0% of the adult population worldwide, according to the Global Initiative for Chronic Obstructive Lung Disease 2021 study. Furthermore, more than 262.0 million people had asthma in 2021, according to the WHO 2022 update. When the natural breathing route is obstructed or restricted, the tracheostomy products offer a breathing passage that aids in breathing. Patients with asthma and other respiratory conditions are strongly advised to take it. In light of this, it is projected that rising respiratory disease incidences will increase demand for tracheostomy products, which will fuel market expansion.

• High prevalence of oral and lung cancer

Patients with head and neck cancers, such as thyroid cancer, oral cancer, and tongue cancer are most frequently treated with tracheostomies. For instance, more than 2.2 million new instances of lung cancer were reported in 2021, according to the World Cancer Research Fund International's 2022 report. Mouth and oral cancers refer to cancers of the lip, oral cavity, hypopharynx, oropharynx, and larynx as a whole. The same source also stated that in 2021, there will be more than 377,700 new instances of malignancies of the lip and oral cavity worldwide. As a result, it is projected that the high prevalence of oral and lung cancer will accelerate market expansion throughout the forecast period.

Opportunities

• Partnerships and collaborations

The market is expanding as a result of partnerships and collaborations between major players, technological developments and rising product approval rates. For instance, in January 2020, Smiths Medical added Portex, a new Polyvinyl Chloride (PVC) tracheostomy tube portfolio, to its line of tracheostomy tubes. The demand for tracheostomy tubes is anticipated to increase as a result of new introductions and an increase in obstructive sleep apnea (OSA) cases, driving the growth during the forecast period.

Restraints/Challenges

• High cost of tonometer devices

High cost of tracheostomy products and the low adoption rate in emerging and underdeveloped countries will obstruct the market's growth rate.

This tracheostomy products market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tracheostomy products market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Tracheostomy Products Market

The COVID-19 pandemic has significantly increased the number of people needing mechanical ventilation and other respiratory assistance. Long-term mechanical breathing is required for these patients but some of them also need tracheostomies to enable weaning and make better use of hospital resources. However, because of the creation of aerosols and the high danger of nosocomial transmission to medical personnel, the tracheostomy technique is challenging to conduct. Although percutaneous tracheostomy (PCT) is the gold standard of care in many ICUs, it poses a greater risk of aerosol production.

Recent Developments

• In 2022, the U.S. FDA warned patients, family members, and medical professionals about the lack of tracheostomy tubes, including ICU Medical's Bivona tracheostomy tubes. Furthermore, the FDA noted that due to a lack of substitute tubes with comparable performance, the shortage of Bivona tracheostomy tubes is more likely to impact young patients.
• In 2022, In order to improve its ability to treat patients with complex respiratory disorders, particularly those who have tracheostomies, Candlewood Valley Health & Rehabilitation partnered with Respiratory Services, LLC.

Asia-Pacific Tracheostomy Products Market Scope

The tracheostomy products market is segmented on the basis of product type, technique, type, material, age group, usability, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Tracheostomy Tubes
• Tracheostomy Catheter
• Tracheostomy Clean
• Care Kits
• Tracheostomy Oxygen Mask
• Collar
• Tracheostomy Dressing
• Tracheostomy Ventilation Accessories
• Cannula 
• Others

 Technique

• Surgical Tracheostomy
• Translaryngeal/Fantoni Tracheostomy
• Percutaneous Dilatational Tracheostomy

 Type

• Closed System 
• Open System

 Material

• Silicone
• Polymer
• Others

Age Group

• Neonatal
• Pediatric
• Adult 
• Geriatric

Usability

• Disposable 
• Reusable

 End User

• Hospita​​​​​​​ls 
• Surgery Centers
• Long Term Assisted Care
• Outpatient Clinic
• Rehabilitation Centers
• Research Laboratories
• Academic Institutes
• Others

 Distribution Channel

• Direct Tender
• Retail Sales

Asia-Pacific Tracheostomy Products Market Regional Analysis/Insights

The tracheostomy products market is analyzed and market size insights and trends are provided by country, product type, technique, type, material, age group, usability, end user and distribution channel as referenced above.

The countries covered in the tracheostomy products market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

China is expected to grow with the most promising growth rate in the forecast period of 2023 to 2030 due of expanding tracheostomy knowledge, COPD incidence and the introduction of COVID-19.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The tracheostomy products market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for tracheostomy products market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tracheostomy products market. The data is available for historic period 2011-2021.

Competitive Landscape and Tracheostomy Products Market Share Analysis

The tracheostomy products market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to tracheostomy products market.

Some of the major players operating in the tracheostomy products market are:

• Medtronic (Ireland)
• Stening SRL (Argentina)
• Cook (U.S.)
• Bicakcilar Medical (Istanbul)
• TROGE MEDICAL GmbH (Germany)
• Henan Tuoren Medical Device Co., Ltd. (China)
• Medis Medical (UK) Ltd (U.K.)
• Pulmodyne, Inc. (U.S.)
• Fuji Systems (Japan)
• DEAS S.R.L. (Italy)
• Sterimed Group (India)
• ConvaTec Group PLC (U.K.)
• ICU Medical, Inc. (U.S.)
• Andreas Fahl Medizintechnik – Vertrieb GmbH (Germany)
• (EUA)
• TRACOE médica GmbH (Alemanha)
• Teleflex Incorporated (EUA)
• Bem Lead Medical Co., Ltd (China) 

SKU-56952